Search
for
Sort by
Research 30 of 1000+
- A new label-free screen for steroid 5α-reductase inhibitors using LC-MS
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- 5α-Reductases in Human Physiology: An Unfolding Story
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Supplementary Material for: Drug-Induced Melasma in Patients on 5-Alpha Reductase Inhibitors: A Case Report
- Supplementary Material for: Drug-Induced Melasma in Patients on 5-Alpha Reductase Inhibitors: A Case Report
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- 5α-Reductases In Human Physiology: an Unfolding Story
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- New 5?-reductase inhibitors: In vitro and in vivo effects
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Clinical use of 5α-reductase inhibitors
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Novel inhibitors of 5α-reductase
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis